It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

In contrast, Eli Lilly (NYSE: LLY) and Hims & Hers Health (NYSE: HIMS) both jumped on today's news. They rose 2.7% and 7%, ...

The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about Ozempic's and Mounjarno's patent cliffs. The scenarios in which Novo ...

This article is part of a featured content programme.

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the Global Prescription Weight-Loss Pills Market 2025-2034," provides a ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs ... to Know Wayfair Is Selling a "Tiny Ranch ...

Kennedy Jr has criticized weight-loss drug manufacturers, saying in October that they were “counting on selling it to Americans because we’re so stupid and so addicted to drugs.” He changed his tune ...

that she had a 'problem' with their slimming pills for 'sustainable weight loss by converting fat into energy'. She said, “This claim of weight loss that you have made, I think I have a problem ...